Updates are available Correction dated 2023-01-30
Click to view Correction: https://doi.org/10.1038/s41575-023-00745-8
-
Authors
Kobayashi, Taku https://orcid.org/0000-0002-2073-4234
Hibi, Toshifumi https://orcid.org/0000-0002-6256-1204
- License Information
-
More Information
Article History
First Online: 12 January 2023
Change Date: 30 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41575-023-00745-8
Competing interests
: T.K. has received lecture fees from Abbie GK, Activaid, Alfresa Pharma, Janssen Pharmaceutical, JIMRO, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Nippon Kayaku, Pfizer Japan, Takeda Pharmaceutical, Thermo Fisher Diagnostics and Zeria Pharmaceutical; research grants from Abbvie GK, Activaid, Alfresa Pharma, Bristol Myers Squibb, Eli Lilly Japan, Ferring Pharmaceuticals, Gilead Sciences, Janssen Pharmaceutical, JMDC, Mochida Pharmaceutical, Nippon Kayaku, Pfizer Japan and Takeda Pharmaceutical; scholarship contributions from Mitsubishi Tanabe Pharma, Nippon Kayaku and Zeria Pharmaceutical; study group sponsorship by Abbvie GK, EA Pharma, JIMRO, Kyorin Pharmaceutical, Mochida Pharmaceutical, Otsuka Holdings and Zeria Pharmaceutical; and advisory or consultancy fees from Abbie GK, Activaid, Alfresa Pharma, EA Pharma, Janssen Pharmaceutical, KISSEI Pharmaceutical, Kyorin Pharmaceutical, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Nippon Kayaku, Pfizer Japan and Takeda Pharmaceutical. T.H. has received lecture fees from Aspen Japan, Janssen, JIMRO, Mitsubishi Tanabe Pharma, Mochida Pharmaceutical, Pfizer and Takeda Pharmaceutical; research grants from AbbVie GK, Activaid, Alfresa Pharma, Bristol Myers Squibb, Eli Lilly Japan, Ferring Pharmaceuticals, Gilead Sciences, Janssen Pharmaceutical, JMDC, Mochida Pharmaceutical, Nippon Kayaku, Pfizer Japan and Takeda Pharmaceutical; scholarship contributions from Mitsubishi Tanabe Pharma, Nippon Kayaku and Zeria Pharmaceutical; and study group sponsorship from AbbVie GK, EA Pharma, JIMRO, Kyorin Pharmaceutical, Mochida Pharmaceutical, Otsuka Holdings and Zeria Pharmaceutical.
